论文部分内容阅读
据香港《文汇报》报道,近年全球受各种流感病毒威胁,包括H7N9及H5N1禽流感等。香港大学医学院与美国国家卫生研究院在天花疫苗中,加入流感病毒基因,成功研发新型甲型流感疫苗,可对抗禽流感病毒H7N9及H5N1、季节性流感H3N2及H1N1,及高致病性H7N7.一旦爆发大型流感,可于短时间内大规模生产疫苗。在老鼠实验中,新疫苗在8个月的保护力达80%至100%。
According to a Hong Kong Wen Wei Po report, in recent years, the world has been threatened by various kinds of influenza viruses, including H7N9 and H5N1 bird flu. The Hong Kong University School of Medicine and the National Institutes of Health have joined the influenza virus gene in the smallpox vaccine to successfully develop a new influenza A vaccine that can fight the bird flu viruses H7N9 and H5N1, seasonal influenza H3N2 and H1N1, and the highly pathogenic H7N7 In the event of a pandemic, vaccines can be produced on a large scale in a short period of time. In mouse experiments, the new vaccine has 80% to 100% protection at 8 months.